Superficial basal cell carcinoma on face treated with 5% imiquimod cream.
Indian J Dermatol Venereol Leprol
;
2006 Sep-Oct; 72(5): 373-5
Article
in English
| IMSEAR
| ID: sea-52622
ABSTRACT
Imiquimod, an immune response modifier, is known to possess both anti-viral and anti-tumor effect. We report our experience of treating a large superficial spreading basal cell carcinoma with 5% imiquimod cream. A 65-year-old male had an asymptomatic, hyperpigmented, slowly progressive, indurated, 3 x 4 cm plaque on the left cheek for two months. Biopsy from the lesion showed features of basal cell carcinoma. The patient was treated with imiquimod 5% cream, topically three times a week for six months with complete resolution of the lesion and without any side-effects. There was no clinical or histological recurrence after three months of stopping the treatment.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Ointments
/
Skin Neoplasms
/
Aged
/
Humans
/
Male
/
Carcinoma, Basal Cell
/
Face
/
Aminoquinolines
Language:
English
Journal:
Indian J Dermatol Venereol Leprol
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS